期刊
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY
卷 30, 期 2, 页码 107-112出版社
FRONTLINE MEDICAL COMMUNICATIONS
DOI: 10.1016/j.sder.2011.05.003
关键词
-
Itch represents a common and significant source of morbidity in the oncological setting. Itch sometimes can be associated with an underlying malignancy, most commonly leukemia or lymphoma. Alternatively, itch may present secondary to malignant invasion causing hepatic or renal dysfunction. Finally, itch may be related to therapeutic regimens for the underlying malignancy. This article seeks to review the clinical scenarios in which itch affects the oncological patient, to briefly present the latest understanding of the molecular and cellular mechanisms of malignancy-related itch, and to review currently available therapeutic options. Semin Cutan Med Surg 30:107-112 (C) 2011 Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据